Biofactories: engineered nanoparticles via genetically engineered organisms

2019 ◽  
Vol 21 (17) ◽  
pp. 4583-4603 ◽  
Author(s):  
Siavash Iravani ◽  
Rajender S. Varma

Latest advances in nanoparticle biosynthesis are highlighted with specific emphasis on the deployment of genetically engineered organisms and associated challenges.

2009 ◽  
Vol 37 (4) ◽  
pp. 732-748 ◽  
Author(s):  
Kristen C. Nelson ◽  
David A. Andow ◽  
Michael J. Banker

Societal evaluation of new technologies, specifically nanotechnology and genetically engineered organisms (GEOs), challenges current practices of governance and science. When a governing body is confronted by a technology whose use has potential environmental risks, some form of risk analysis is typically conducted to help decision makers consider the range of possible benefits and harms posed by the technology. Environmental risk assessment (ERA) is a critical component in the governance of nanotechnology and genetically engineered organisms because the uncertainties and complexities surrounding these technologies pose such risk potential. However, GEOs are unique technologies, and there is widespread, international recognition (e.g., the Cartagena Protocol on Biosafety of Living Modified Organisms) that many traditional forms of ERA are not well-suited for evaluating them. Nanotechnology products are also likely to need different models of risk assessment, as there is very little information on their fate, transport, and impacts in the environment.


Sign in / Sign up

Export Citation Format

Share Document